東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Implications for the androgenic regu...

University of Delaware., Department of Biological Sciences.

Linked to FindBook

Google Book

Amazon

博客來

Implications for the androgenic regulation of IGFBP-2 in the development of metastatic and androgen independent prostate cancer.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Implications for the androgenic regulation of IGFBP-2 in the development of metastatic and androgen independent prostate cancer./
Author:	DeGraff, David J.
Description:	160 p.
Notes:	Adviser: Robert A. Sikes.
Contained By:	Dissertation Abstracts International69-01B.
Subject:	Biology, Cell. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3291688
ISBN:	9780549386735

Implications for the androgenic regulation of IGFBP-2 in the development of metastatic and androgen independent prostate cancer.
DeGraff, David J.

Implications for the androgenic regulation of IGFBP-2 in the development of metastatic and androgen independent prostate cancer. - 160 p.

Adviser: Robert A. Sikes.

Thesis (Ph.D.)--University of Delaware, 2008.

The insulin-like growth factor (IGF) axis consists of two ligands (IGF-I and IGF-II), two receptors (IGF1R and IGF2R), as well as a family of closely related IGF binding proteins (IGFBP 1-6). It is generally considered that altered expression in IGF axis members is associated with the development of several cancers. Elevated expression of IGFBP-2 is directly correlated with both the in vitro aggressive behavior and clinical presentation of metastatic ovarian, breast, adrenal, and central nervous system cancers. However, a role, if any, for IGFBP-2 in metastatic androgen independent prostate cancer (AI PCa) is unknown. Additionally, while alterations in IGFBP-2 expression are associated with progression to AI PCa, published reports regarding the influence of androgen treatment on the most commonly utilized androgen sensitive (AS) PCa cell line, LNCaP are contradictory. Therefore, we undertook an analysis of first, the influence of androgen treatment on IGFBP-2 expression in LNCaP, and second, the role of IGFBP-2 in the metastatic nature of AI PCa. In summary, we report the following in regard to the regulation of IGFBP-2 expression in LNCaP human PCa cells following treatment with the synthetic androgen R1881: (1) R1881 treatment produces an initial increase in steady state levels of IGFBP-2 mRNA, followed by a time dependent decrease in steady state levels of IGFBP-2 mRNA, (2) R1881 treatment results in decreased levels of intracellular IGFBP-2 in Triton-x-100 soluble locales, as well as the increased nuclear localization of IGFBP-2, and (3) through the apparent action of an as yet unidentified serine protease, R1881 treatment results in the limited proteolysis of IGFBP-2 and a subsequent decrease in intact extracellular IGFBP-2. Furthermore, we demonstrate that (4) IGFBP-2 is a substrate for androgen-induced proteolysis in PCa cells with a functional androgen receptor (AR), (5) the ability of IGFBP-2 to undergo androgen-induced proteolysis is attenuated greatly with progression to AI and is inversely correlated with in vivo metastatic potential, and (6) androgen-induced IGFBP-2 proteolysis results in decreased binding to IGFs, and thus has functional consequences. In regard to the role of IGFBP-2 in the facilitation of the aggressive phenotype attributed to metastatic PCa, we show that IGFBP-2 treatment (7) increased LNCaP levels of phosphorylated focal adhesion kinase (FAK) in both a concentration and time dependent manner, (8) significantly increased the invasion of LNCaP cells, and (9) increased the migration of non-metastatic, poorly motile LNCaP cells. In summary, our results indicate that IGFBP-2 expression is repressed in AS LNCaP human PCa cells in an androgen containing environment, resulting in a significant decease in extracellular IGFBP-2 levels. Furthermore, our results indicate that decreases in secreted levels of IGFBP-2 achieved via extracellular proteolysis are lost with progression to AI, and this increase in extracellular IGFBP-2 may facilitate the metastatic behavior of AI PCa cells.

ISBN: 9780549386735Subjects--Topical Terms:

1017686
Biology, Cell.

Implications for the androgenic regulation of IGFBP-2 in the development of metastatic and androgen independent prostate cancer.
LDR:04268nam 2200349 a 45 001 856619
005 20100709
008 100709s2008 ||||||||||||||||| ||eng d
020 $a 9780549386735
035 $a (UMI)AAI3291688
035 $a AAI3291688
040 $a UMI $c UMI
100 1 $a DeGraff, David J. $3 1023448
245 1 0 $a Implications for the androgenic regulation of IGFBP-2 in the development of metastatic and androgen independent prostate cancer.
300 $a 160 p.
500 $a Adviser: Robert A. Sikes.
500 $a Source: Dissertation Abstracts International, Volume: 69-01, Section: B, page: 0152.
502 $a Thesis (Ph.D.)--University of Delaware, 2008.
520 $a The insulin-like growth factor (IGF) axis consists of two ligands (IGF-I and IGF-II), two receptors (IGF1R and IGF2R), as well as a family of closely related IGF binding proteins (IGFBP 1-6). It is generally considered that altered expression in IGF axis members is associated with the development of several cancers. Elevated expression of IGFBP-2 is directly correlated with both the in vitro aggressive behavior and clinical presentation of metastatic ovarian, breast, adrenal, and central nervous system cancers. However, a role, if any, for IGFBP-2 in metastatic androgen independent prostate cancer (AI PCa) is unknown. Additionally, while alterations in IGFBP-2 expression are associated with progression to AI PCa, published reports regarding the influence of androgen treatment on the most commonly utilized androgen sensitive (AS) PCa cell line, LNCaP are contradictory. Therefore, we undertook an analysis of first, the influence of androgen treatment on IGFBP-2 expression in LNCaP, and second, the role of IGFBP-2 in the metastatic nature of AI PCa. In summary, we report the following in regard to the regulation of IGFBP-2 expression in LNCaP human PCa cells following treatment with the synthetic androgen R1881: (1) R1881 treatment produces an initial increase in steady state levels of IGFBP-2 mRNA, followed by a time dependent decrease in steady state levels of IGFBP-2 mRNA, (2) R1881 treatment results in decreased levels of intracellular IGFBP-2 in Triton-x-100 soluble locales, as well as the increased nuclear localization of IGFBP-2, and (3) through the apparent action of an as yet unidentified serine protease, R1881 treatment results in the limited proteolysis of IGFBP-2 and a subsequent decrease in intact extracellular IGFBP-2. Furthermore, we demonstrate that (4) IGFBP-2 is a substrate for androgen-induced proteolysis in PCa cells with a functional androgen receptor (AR), (5) the ability of IGFBP-2 to undergo androgen-induced proteolysis is attenuated greatly with progression to AI and is inversely correlated with in vivo metastatic potential, and (6) androgen-induced IGFBP-2 proteolysis results in decreased binding to IGFs, and thus has functional consequences. In regard to the role of IGFBP-2 in the facilitation of the aggressive phenotype attributed to metastatic PCa, we show that IGFBP-2 treatment (7) increased LNCaP levels of phosphorylated focal adhesion kinase (FAK) in both a concentration and time dependent manner, (8) significantly increased the invasion of LNCaP cells, and (9) increased the migration of non-metastatic, poorly motile LNCaP cells. In summary, our results indicate that IGFBP-2 expression is repressed in AS LNCaP human PCa cells in an androgen containing environment, resulting in a significant decease in extracellular IGFBP-2 levels. Furthermore, our results indicate that decreases in secreted levels of IGFBP-2 achieved via extracellular proteolysis are lost with progression to AI, and this increase in extracellular IGFBP-2 may facilitate the metastatic behavior of AI PCa cells.
590 $a School code: 0060.
650 4 $a Biology, Cell. $3 1017686
650 4 $a Biology, Molecular. $3 1017719
650 4 $a Biology, Physiology. $3 1017816
690 $a 0307
690 $a 0379
690 $a 0719
710 2 $a University of Delaware. $b Department of Biological Sciences. $3 1023447
773 0 $t Dissertation Abstracts International $g 69-01B.
790 $a 0060
790 1 0 $a Carson, Daniel D. $e committee member
790 1 0 $a Cooper, Carlton R. $e committee member
790 1 0 $a Duncan, Melinda K. $e committee member
790 1 0 $a Koh, John T. $e committee member
790 1 0 $a Mason, Robert W. $e committee member
790 1 0 $a Sikes, Robert A., $e advisor
791 $a Ph.D.
792 $a 2008
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3291688